Cabot Corporation (NYSE:CBT) – Stock analysts at Northcoast Research issued their Q1 2018 earnings estimates for Cabot Corporation in a research note issued on Thursday, according to Zacks Investment Research. Northcoast Research analyst K. Hocevar expects that the specialty chemicals company will post earnings per share of $0.79 for the quarter. Northcoast Research also issued estimates for Cabot Corporation’s Q2 2018 earnings at $1.00 EPS, Q3 2018 earnings at $1.02 EPS, Q4 2018 earnings at $0.99 EPS and FY2018 earnings at $3.80 EPS.
Cabot Corporation (NYSE:CBT) last released its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.93 by ($0.02). The company had revenue of $723.00 million for the quarter, compared to analyst estimates of $683.30 million. Cabot Corporation had a return on equity of 15.11% and a net margin of 8.87%. Cabot Corporation’s revenue for the quarter was up 16.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.00 earnings per share.
Several other equities analysts have also recently issued reports on CBT. Zacks Investment Research cut shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. ValuEngine cut shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Friday, July 28th. BidaskClub lowered shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. J P Morgan Chase & Co raised shares of Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a research note on Tuesday, August 15th. Finally, Loop Capital initiated coverage on shares of Cabot Corporation in a research note on Thursday, September 28th. They issued a “hold” rating and a $59.00 price objective on the stock. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $61.14.
Cabot Corporation (CBT) traded down $1.33 during mid-day trading on Monday, reaching $60.24. 406,100 shares of the company were exchanged, compared to its average volume of 340,551. The firm has a market cap of $3,810.22, a PE ratio of 17.95, a price-to-earnings-growth ratio of 1.63 and a beta of 1.11. Cabot Corporation has a twelve month low of $50.21 and a twelve month high of $64.66. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.17 and a current ratio of 1.70.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 8th. Stockholders of record on Friday, November 24th will be issued a $0.315 dividend. The ex-dividend date of this dividend is Wednesday, November 22nd. This represents a $1.26 annualized dividend and a dividend yield of 2.09%. Cabot Corporation’s dividend payout ratio is currently 33.07%.
In other news, insider Hobart Kalkstein sold 3,881 shares of the stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $53.39, for a total value of $207,206.59. Following the completion of the sale, the insider now owns 27,736 shares in the company, valued at $1,480,825.04. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 2.50% of the company’s stock.
Several hedge funds have recently made changes to their positions in CBT. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Cabot Corporation by 9.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,469 shares of the specialty chemicals company’s stock worth $132,000 after buying an additional 209 shares during the last quarter. Old Mutual Global Investors UK Ltd. purchased a new stake in Cabot Corporation during the second quarter worth about $155,000. Integrated Investment Consultants LLC increased its holdings in Cabot Corporation by 66.1% during the second quarter. Integrated Investment Consultants LLC now owns 3,097 shares of the specialty chemicals company’s stock worth $165,000 after buying an additional 1,233 shares during the last quarter. Parametrica Management Ltd purchased a new stake in Cabot Corporation during the third quarter worth about $217,000. Finally, Virginia Retirement Systems ET AL purchased a new stake in Cabot Corporation during the third quarter worth about $218,000. Institutional investors own 84.28% of the company’s stock.
About Cabot Corporation
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.